GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » Change In Receivables

Univo Pharmaceuticals (XTAE:UNVO-M) Change In Receivables : ₪0.36 Mil (TTM As of Jun. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Univo Pharmaceuticals Change In Receivables?

Univo Pharmaceuticals's change in receivables for the quarter that ended in Jun. 2022 was ₪0.55 Mil. It means Univo Pharmaceuticals's Accounts Receivable declined by ₪0.55 Mil from Mar. 2022 to Jun. 2022 .

Univo Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2021 was ₪-5.01 Mil. It means Univo Pharmaceuticals's Accounts Receivable increased by ₪5.01 Mil from Dec. 2020 to Dec. 2021 .

Univo Pharmaceuticals's Accounts Receivable for the quarter that ended in Jun. 2022 was ₪8.60 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Univo Pharmaceuticals's Days Sales Outstanding for the three months ended in Jun. 2022 was 74.32.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Univo Pharmaceuticals's liquidation value for the three months ended in Jun. 2022 was ₪-35.70 Mil.


Univo Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Univo Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Univo Pharmaceuticals Change In Receivables Chart

Univo Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Change In Receivables
Get a 7-Day Free Trial Premium Member Only -0.02 -0.52 -0.60 -7.90 -5.01

Univo Pharmaceuticals Quarterly Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.88 1.49 -5.42 3.73 0.55

Univo Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Univo Pharmaceuticals  (XTAE:UNVO-M) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Univo Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=8.602/10.562*91
=74.32

2. In Ben Graham's calculation of liquidation value, Univo Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Univo Pharmaceuticals's liquidation value for the quarter that ended in Jun. 2022 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=4.504-55.437+0.75 * 8.602+0.5 * 17.559
=-35.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Univo Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Univo Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Univo Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Harshar 20, Ashkelon, ISR, 7878329
Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Univo Pharmaceuticals Headlines

No Headlines